Eisai Wants Aurobindo's Generic Weight Loss Drug Blocked
Eisai Inc. has accused Aurobindo Pharma LTD in Delaware federal court of infringing six patents covering its weight loss drug Belviq....To view the full article, register now.
Already a subscriber? Click here to view full article